Aalborg University Hospital

BiliCocoon Phototherapy Shows Comparable Efficacy to Overhead Treatment for Neonatal Hyperbilirubinemia

7 months ago

• A recent study compared the efficacy of BiliCocoon, a novel phototherapy device, with traditional overhead phototherapy for treating hyperbilirubinemia in newborns. • The trial, involving 83 neonates, found that BiliCocoon achieved a similar reduction in total serum bilirubin (TSB) levels compared to overhead phototherapy over 24 hours. • BiliCocoon offers the advantage of not requiring eye protection, potentially improving infant comfort during treatment, while maintaining comparable safety profiles. • These findings suggest BiliCocoon as an effective alternative to overhead phototherapy, expanding options for managing neonatal hyperbilirubinemia.

Brain+ Initiates Clinical Trial of BrainBlossom for Mild Cognitive Impairment

9 months ago

• Brain+ has commenced a clinical trial to evaluate BrainBlossom, a next-generation cognitive training technology, for individuals with Mild Cognitive Impairment (MCI). • The randomized, controlled trial will assess the feasibility and impact of BrainBlossom in 40 participants with MCI over a four-week, at-home training program. • Expected results in early 2025 will determine the next steps, including a larger clinical trial for regulatory data and potential pharmaceutical partnerships. • BrainBlossom builds upon validated cognitive training methods and aims to provide scalable, home-based therapeutic delivery for the large MCI population.